Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the target of unusually large options trading activity on Wednesday. Investors purchased 1,885 put options on the stock. This is an increase of approximately 1,101% compared to the average daily volume of 157 put options.
Evelo Biosciences Stock Performance
EVLO opened at $0.00 on Friday. Evelo Biosciences has a one year low of $0.00 and a one year high of $0.00. The company has a market cap of $9,420.00, a PE ratio of 0.00 and a beta of 0.68.
About Evelo Biosciences
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.
The company’s pipeline spans inflammatory, autoimmune and oncology indications.
Further Reading
- Five stocks we like better than Evelo Biosciences
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- How the Rich Retire
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
